Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Hepatology (Baltimore, Md.)
|
March 1, 1993
Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts
T C Peterson
Biochemical Pharmacology
|
November 15, 1987
Drug-metabolizing enzymes in rat, mouse, pig and human macrophages and the effect of phagocytic activation
T C Peterson
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
February 1, 1991
Monocyte arylhydrocarbon hydroxylase activity and mortality
T C Peterson
Canadian Journal of Physiology and Pharmacology
|
November 1, 1988
Effect of chronic cysteamine treatment on mouse liver aryl hydrocarbon hydroxylase activity
T C Peterson
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses
|
April 20, 2012
Therapeutic potential for cytokine antagonists: Thalidomide and pentoxifylline in Hansen's disease
T C Peterson
Biochemical Pharmacology
|
March 3, 1992
Interleukin-1, platelet derived growth factor, free radicals and monocyte aryl hydrocarbon hydroxylase activity in liver disease. Role of cell communication
T C Peterson
Biochemical Pharmacology
|
August 23, 1996
Inhibition of fibroproliferation by pentoxifylline. Activity of metabolite-1 and lack of role of adenosine receptors
T C Peterson
Immunopharmacology
|
March 1, 1996
Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism
T C Peterson, M Neumeister
Alimentary Pharmacology & Therapeutics
|
June 1, 1997
Effect of acute pentoxifylline treatment in an experimental model of colitis
T C Peterson, K Davey
Biochemical Pharmacology
|
March 27, 1998
Drug-metabolizing enzymes in rat liver myofibroblasts
T C Peterson, G Rowden
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Hepatology (Baltimore, Md.)
|
March 1, 1993
Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts
T C Peterson
Biochemical Pharmacology
|
November 15, 1987
Drug-metabolizing enzymes in rat, mouse, pig and human macrophages and the effect of phagocytic activation
T C Peterson
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
February 1, 1991
Monocyte arylhydrocarbon hydroxylase activity and mortality
T C Peterson
Canadian Journal of Physiology and Pharmacology
|
November 1, 1988
Effect of chronic cysteamine treatment on mouse liver aryl hydrocarbon hydroxylase activity
T C Peterson
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses
|
April 20, 2012
Therapeutic potential for cytokine antagonists: Thalidomide and pentoxifylline in Hansen's disease
T C Peterson
Biochemical Pharmacology
|
March 3, 1992
Interleukin-1, platelet derived growth factor, free radicals and monocyte aryl hydrocarbon hydroxylase activity in liver disease. Role of cell communication
T C Peterson
Biochemical Pharmacology
|
August 23, 1996
Inhibition of fibroproliferation by pentoxifylline. Activity of metabolite-1 and lack of role of adenosine receptors
T C Peterson
Immunopharmacology
|
March 1, 1996
Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism
T C Peterson, M Neumeister
Alimentary Pharmacology & Therapeutics
|
June 1, 1997
Effect of acute pentoxifylline treatment in an experimental model of colitis
T C Peterson, K Davey
Biochemical Pharmacology
|
March 27, 1998
Drug-metabolizing enzymes in rat liver myofibroblasts
T C Peterson, G Rowden
Page
of 4